The Use of Artificial Neural Networks for the Diagnosis and Estimation of Prognosis in Cancer Patients

Outcome Prediction in Cancer

Volumn , Issue , 2007, Pages 243-259

  Mario Marchevsky, Alberto ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Artificial neural networks; backpropagation neural networks; cancer diagnosis; cancer prognosis; data overfit; model validation; multivariate statistical methods; neuronal architecture; neurons; probabilistic neural networks

Indexed keywords

EID: 80051893844     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452855-1/50011-8     Document Type: Chapter

References (88)

1. H.A. Abbass (2002) An evolutionary artificial neural networks approach for breast cancer diagnosis. Artif. Intell. Med. 25(3), 265-281.
2. T. Anagnostou, M. Remzi, M. Lykourinas and B. Djavan (2003) Artificial neural networks for decision-making in urologic oncology. Eur. Urol. 43(6), 596-603.
3. M. Aoyama, Q. Li, S. Katsuragawa, H. MacMahon and K. Doi (2002) Automated computerized scheme for distinction between benign and malignant solitary pulmonary nodules on chest images. Med. Phys. 29(5), 701-708.
4. Y. Attikiouzel and C.J. deSilva (1995) Applications of neural networks in medicine. Australas. Phys. Eng. Sci. Med. 18(3), 158-164.
5. R.J. Babaian and Z. Zhang (2001) Computer-assisted diagnostics: application to prostate cancer. Mol. Urol. 5(4), 175-180.
6. G. Ball, S. Mian, F. Holding, R.O. Allibone, J. Lowe, S. Ali, G. Li, S. McCardle, I.O. Ellis, C. Creaser and R.C. Rees (2002) An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics 18(3), 395-404.
7. J.T. Batuello, E.J. Gamito, E.D. Crawford, M. Han, A.W. Partin, D.G. McLeod and C. O'Donnell (2001) Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. Urology 57(3), 481-485.
8. R.L. Becker (1994) Computer-assisted image classification: use of neural networks in anatomic pathology. Cancer Lett. 77(2–3), 111-117.
9. M. Bellotti, B. Elsner, L.A. Paez De, H. Esteva and A.M. Marchevsky (1997) Neural networks as a prognostic tool for patients with non-small-cell carcinoma of the lung. Mod. Pathol. 10(12), 1221-1227.
10. R. Biagiotti, C. Desii, E. Vanzi and G. Gacci (1999) Predicting ovarian malignancy: application of artificial neural networks to transvaginal and color Doppler flow US. Radiology 210(2), 399-403.
11. E. Biganzoli, P. Boracchi, D. Coradini, D.M. Grazia and E. Marubini (2003) Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factors 2772. Ann. Oncol. 14(10), 1484-1493.
12. I.J. Bigio, S.G. Bown, G. Briggs, C. Kelley, S. Lakhani, D. Pickard, P.M. Ripley, I.G. Rose and C. Saunders (2000) Diagnosis of breast cancer using elastic-scattering spectroscopy: preliminary clinical results. J. Biomed. Opt. 5(2), 221-228.
13. M. Binder, A. Steiner, M. Schwarz, S. Knollmayer, K. Wolff and H. Pehamberger (1994) Application of an arti-ficial neural network in epiluminescence microscopy pattern analysis of pigmented skin lesions: a pilot study. Br. J. Dermatol. 130(4), 460-465.
14. G. Bloom, I.V. Yang, D. Boulware, K.Y. Kwong, D. Coppola, S. Eschrich, J. Quackenbush and T.J. Yeatman (2004) Multi-platform, multi-site, microarray-based human tumor classification. Am. J. Pathol. 164(1), 9-16.
15. E.H. Bollschweiler, S.P. Monig, K. Hensler, S.E. Baldus, K. Maruyama and A.H. Holscher (2004) Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study. Ann. Surg. Oncol. 11(5), 506-511.
16. P. Boracchi, E. Biganzoli and E. Marubini (2001) Modelling cause-specific hazards with radial basis function artificial neural networks: application to 2233 breast cancer patients. Stat. Med. 20(24), 3677-3694.
17. D.G. Bostwick and H.B. Burke (2001) Prediction of individual patient outcome in cancer: comparison of artificial neural networks and Kaplan-Meier methods. Cancer 91(Suppl 8), 1643-1646.
18. L. Bottaci, P.J. Drew, J.E. Hartley, M.B. Hadfield, R. Farouk, P.W. Lee, I.M. Macintyre, G.S. Duthie and J.R. Monson (1997) Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions. Lancet 350(9076), 469-472.
19. H.B. Burke (1994) Artificial neural networks for cancer research: outcome prediction. Semin. Surg. Oncol. 10(1), 73-79.
20. H.B. Burke, P.H. Goodman, D.B. Rosen, D.E. Henson, J.N. Weinstein, F.E. Harrell Jr., J.R. Marks, D.P. Winchester and D.G. Bostwick (1997) Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 79(4), 857-862.
21. M. Buyse and P. Piedbois (1997) Artificial neural networks. Lancet 350(9085), 1175-1176.
22. J.W. Catto, D.A. Linkens, M.F. Abbod, M. Chen, J.L. Burton, K.M. Feeley and F.C. Hamdy (2003) Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks. Clin. Cancer Res. 9(11), 4172-4177.
23. Y.D. Chen, S. Zheng, J.K. Yu and X. Hu (2004) Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from popu-lation. Clin. Cancer Res. 10(24), 8380-8385.
24. G. Coppini, S. Diciotti, M. Falchini, N. Villari and G. Valli (2003) Neural networks for computer-aided diagno-sis: detection of lung nodules in chest radiograms. IEEE Trans. Inf. Technol. Biomed. 7(4), 344-357.
25. E.D. Crawford (2003) Use of algorithms as determinants for individual patient decision making: national comprehensive cancer network versus artificial neural networks. Urology 62(6 Suppl 1), 13-19.
26. R. Danesi and A.D. Paolo (2003) Predicting survival with artificial neural networks. Clin. Colorectal Cancer 2(4), 245.
27. L. Deligdisch, A.J. Einstein, D. Guera and J. Gil (1995) Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks. Cancer 76(6), 1027-1034.
28. B. Djavan, M. Remzi, A. Zlotta, C. Seitz, P. Snow and M. Marberger (2002) Novel artificial neural network for early detection of prostate cancer. J. Clin. Oncol. 20(4), 921-929.
29. T.H. Douglas and J.W. Moul (1998) Applications of neural networks in urologic oncology. Semin. Urol. Oncol. 16(1), 35-39.
30. S. Dreiseitl, L. Ohno-Machado, H. Kittler, S. Vinterbo, H. Billhardt and M. Binder (2001) A comparison of machine learning methods for the diagnosis of pigmented skin lesions. J. Biomed. Inform. 34(1), 28-36.
31. K. Droste, E. Bollschweiler, T. Waschulzik, T. Schutz, R. Engelbrecht, K. Maruyama and J.R. Siewert (1996) Prediction of lymph node metastasis in gastric cancer patients with neural networks. Cancer Lett. 109(1–2), 141-148.
32. R. Dua, D.G. Beetner, W.V. Stoecker and D.C. Wunsch (2004) Detection of basal cell carcinoma using electrical impedance and neural networks. IEEE Trans. Biomed. Eng. 51(1), 66-71.
33. R. Eberhart, P. Simpson and R. Dobbins (1996) Computational Intelligence PC Tools. New York, NY: Academic Press
34. A. Errejon, E.D. Crawford, J. Dayhoff, C. O'Donnell, A. Tewari, J. Finkelstein and E.J. Gamito (2001) Use of artificial neural networks in prostate cancer. Mol. Urol. 5(4), 153-158.
35. H. Esteva, M. Bellotti and A.M. Marchevsky (2001) Neural networks for the estimation of prognosis in lung cancer. R.N.G. Naguib (Ed.) Artificial Neural Networks in Cancer Diagnosis, Prognosis and Patient Management Boca Raton, Florida: CRC Press 29-38.
36. D.B. Fogel, E.C. Wasson III, E.M. Boughton and V.W. Porto (1998) Evolving artificial neural networks for screening features from mammograms. Artif. Intell. Med. 14(3), 317-326.
37. D.B. Fogel, E.C. Wasson, E.M. Boughton, V.W. Porto and P.J. Angeline (1998) Linear and neural models for classifying breast masses. IEEE Trans. Med. Imaging. 17(3), 485-488.
38. K. Fujikawa, Y. Matsui, T. Kobayashi, K. Miura, H. Oka, S. Fukuzawa, M. Sasaki, H. Takeuchi and T. Okabe (2003) Predicting disease outcome of non-invasive transitional cell carcinoma of the urinary bladder using an artificial neural network model: results of patient fol for 15 years or longer. Int. J. Urol. 10(3), 149-152.
39. E.J. Gamito and E.D. Crawford (2004) Artificial neural networks for predictive modeling in prostate cancer. Curr. Oncol. Rep. 6(3), 216-221.
40. S.R. Grey, S.S. Dlay, B.E. Leone, F. Cajone and G.V. Sherbet (2003) Prediction of nodal spread of breast cancer by using artificial neural network-based analyses of S100A4. nm23 and steroid receptor expression. Clin. Exp. Metastasis 20(6), 507-514.
41. S.A. Grumett and P.B. Snow (2000) Artificial neural networks: a new model for assessing prognostic factors. Ann. Oncol. 11(4), 383-384.
42. S.L. Gulliford, S. Webb, C.G. Rowbottom, D.W. Corne and D.P. Dearnaley (2004) Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. Radiother. Oncol. 71(1), 3-12.
43. S. Halkiotis and J. Mantas (2002) Automatic detection of clustered microcalcifications in digital mammograms. Stud. Health Technol. Inform. 90 24-29.
44. M. Han, P.B. Snow, J.M. Brandt and A.W. Partin (2001) Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma. Cancer 91(Suppl 8), 1661-1666.
45. T. Hanai, Y. Yatabe, Y. Nakayama, T. Takahashi, H. Honda, T. Mitsudomi and T. Kobayashi (2003) Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression. Cancer Sci. 94(5), 473-477.
46. T.C. Hsia, H.C. Chiang, D. Chiang, L.W. Hang, F.J. Tsai and W.C. Chen (2003) Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters. J. Clin. Lab Anal. 17(6), 229-234.
47. S.W. Looney (2002) Biostatistical Methods. Totawa, N.J.: Humana Press
48. A.M. Marchevsky and M.R. Wick (2004) Evidence-based medicine, medical decision analysis, and pathology. Hum. Pathol. 35(10), 1179-1188.
49. A.M. Marchevsky, S. Patel, K.J. Wiley, M.A. Stephenson, M. Gondo, R.W. Brown, E.S. Yi, W.F. Benedict, R.C. Anton and P.T. Cagle (1998) Artificial neural networks and logistic regression as tools for prediction of survival in patients with stages I and II non-small-cell lung cancer. Mod. Pathol. 11(7), 618-625.
50. A.M. Marchevsky, S. Shah and S. Patel (1999) Reasoning with uncertainty in pathology: artificial neural networks and logistic regression as tools for prediction of lymph node status in breast cancer pati. Mod. Pathol. 12(5), 505-513.
51. A.M. Marchevsky, J.A. Tsou and I.A. Laird-Offringa (2004) Classification of individual lung cancer cell lines based on DNA methylation markers: use of linear discriminant analysis and artificial neural networks. J. Mol. Diagn. 6(1), 28-36.
52. T. Mattfeldt, H.A. Kestler, R. Hautmann and H.W. Gottfried (2001) Prediction of postoperative prostatic cancer stage on the basis of systematic biopsies using two types of artificial neural networks. Eur. Urol. 39(5), 530-536.
53. T. Mattfeldt, H. Wolter, R. Kemmerling, H.W. Gottfried and H.A. Kestler (2001) Cluster analysis of compara-tive genomic hybridization (CGH) data using self-organizing maps: application to prostate carcinomas. Anal. Cell Pathol. 23(1), 29-37.
54. J.E. Montie and J.T. Wei (2001) Artificial neural networks for prostate carcinoma risk assessment. An overview. Cancer 91(Suppl 8), 1647-1652.
55. G.P. Murphy, P. Snow, S.J. Simmons, B.A. Tjoa, M.K. Rogers, J. Brandt, C.G. Healy, W.E. Bolton and D. Rodbold (2000) Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer pa. Prostate 42(1), 67-72.
56. R.N.G. Naguib (2001) Artificial Neural Networks in Cancer Diagnosis, Prognosis, and Patient Management. Boca Raton, Florida, US: CRC Press
57. R.N. Naguib and G.V. Sherbet (1997) Artificial neural networks in cancer research. Pathobiology 65(3), 129-139.
58. R.N. Naguib, A.E. Adams, C.H. Horne, B. Angus, A.F. Smith, G.V. Sherbet and T.W. Lennard (1997) Prediction of nodal metastasis and prognosis in breast cancer: a neural model. Anticancer Res. 17(4A), 2735-2741.
59. R.N. Naguib, M.C. Robinson, D.E. Neal and F.C. Hamdy (1998) Neural network analysis of combined conven-tional and experimental prognostic markers in prostate cancer: a pilot study. Br. J. Cancer 78(2), 246-250.
60. R.N. Naguib, H.A. Sakim, M.S. Lakshmi, V. Wadehra, T.W. Lennard, J. Bhatavdekar and G.V. Sherbet (1999) DNA ploidy and cell cycle distribution of breast cancer aspirate cells measured by image cytometry and analyzed by artificial neural networks for their progno. IEEE Trans. Inf. Technol. Biomed. 3(1), 61-69.
61. K. Nakamura, H. Yoshida, R. Engelmann, H. MacMahon, S. Katsuragawa, T. Ishida, K. Ashizawa and K. Doi (2000) Computerized analysis of the likelihood of malignancy in solitary pulmonary nodules with use of artifi-cial neural networks. Radiology 214(3), 823-830.
62. A. Narayanan, E.C. Keedwell and B. Olsson (2002) Artificial intelligence techniques for bioinformatics. Appl. Bioinformatics 1(4), 191-222.
63. E.Y. Ng, S.C. Fok, Y.C. Peh, F.C. Ng and L.S. Sim (2002) Computerized detection of breast cancer with artifi-cial intelligence and thermograms. J. Med. Eng Technol. 26(4), 152-157.
64. T. Ochi, K. Murase, T. Fujii, M. Kawamura and J. Ikezoe (2002) Survival prediction using artificial neural networks in patients with uterine cervical cancer treated by radiation therapy alone. Int. J. Clin. Oncol. 7(5), 294-300.
65. M.C. O'Neill and L. Song (2003) Neural network analysis of lymphoma microarray data: prognosis and diagno-sis near-perfect. BMC Bioinformatics 4(1), 13.
66. C.R. Porter and E.D. Crawford (2003) Combining artificial neural networks and transrectal ultrasound in the diagnosis of prostate cancer. Oncology (Huntingt) 17(10), 1395-1399.
67. M. Ringner and C. Peterson (2003) Microarray-based cancer diagnosis with artificial neural networks. Biotechniques 34(Suppl 3), 30-35.
68. S.K. Rogers, D.W. Ruck and M. Kabrisky (1994) Artificial neural networks for early detection and diagnosis of cancer. Cancer Lett. 77(2–3), 79-83.
69. D.W. Rolston (1988) Principles of Artificial Intelligence and Expert System Development. New York, NY, USA: McGraw-Hill
70. A.L. Ronco (1999) Use of artificial neural networks in modeling associations of discriminant factors: towards an intelligent selective breast cancer screening. Artif. Intell. Med. 16(3), 299-309.
71. S. Russell and P. Norvig (1995) Artificial Intelligence. A Modern Approach Upple Saddle Valley, New Jersey: Prentice Hall
72. D.J. Sargent (2001) Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer 91(Suppl 8), 1636-1642.
73. M. Schumacher, E. Graf and T. Gerds (2003) How to assess prognostic models for survival data: a case study in oncology. Methods Inf. Med. 42(5), 564-571.
74. G. Schwarzer, W. Vach and M. Schumacher (2000) On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat. Med. 19(4), 541-561.
75. H. Seker, M.O. Odetayo, D. Petrovic, R.N. Naguib, C. Bartoli, L. Alasio, M.S. Lakshmi and G.V. Sherbet (2002) Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: statistical, neural network and fuzzy approaches. Anticancer Res. 22(1A), 433-438.
76. F.M. Selaru, Y. Xu, J. Yin, T. Zou, T.C. Liu, Y. Mori, J.M. Abraham, F. Sato, S. Wang, C. Twigg, A. Olaru, V. Shustova, A. Leytin, P. Hytiroglou, D. Shibata, N. Harpaz and S.J. Meltzer (2002) Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 122(3), 606-613.
77. R.P. Singson, R. Alsabeh, S.A. Geller and A. Marchevsky (1999) Estimation of tumor stage and lymph node status in patients with colorectal adenocarcinoma using probabilistic neural networks and logistic regression. Mod. Pathol. 12(5), 479-484.
78. P.B. Snow, D.M. Rodvold and J.M. Brandt (1999) Artificial neural networks in clinical urology. Urology 54(5), 787-790.
79. P.B. Snow, D.J. Kerr, J.M. Brandt and D.M. Rodvold (2001) Neural network and regression predictions of 5-year survival after colon carcinoma treatment. Cancer 91(Suppl 8), 1673-1678.
80. B.K. Szabo, M.K. Wiberg, B. Bone and P. Aspelin (2004) Application of artificial neural networks to the analysis of dynamic MR imaging features of the breast. Eur. Radiol. 14(7), 1217-1225.
81. A.F. Taktak, A.C. Fisher and B.E. Damato (2004) Modelling survival after treatment of intraocular melanoma using artificial neural networks and Bayes theorem. Phys. Med. Biol. 49(1), 87-98.
82. G.D. Tourassi, M.K. Markey, J.Y. Lo and C.E. Floyd Jr. (2001) A neural network approach to breast cancer diagnosis as a constraint satisfaction problem. Med. Phys. 28(5), 804-811.
83. J.S. Wei, B.T. Greer, F. Westermann, S.M. Steinberg, C.G. Son, Q.R. Chen, C.C. Whiteford, S. Bilke, A.L. Krasnoselsky, N. Cenacchi, D. Catchpoole, F. Berthold, M. Schwab and J. Khan (2004) Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma. Cancer Res. 64(19), 6883-6891.
84. J.T. Wei, Z. Zhang, S.D. Barnhill, K.R. Madyastha, H. Zhang and J.E. Oesterling (1998) Understanding artificial neural networks and exploring their potential applications for the practicing urologist. Urology 52(2), 161-172.
85. Y.C. Wu, K. Doi and M.L. Giger (1995) Detection of lung nodules in digital chest radiographs using artificial neural networks: a pilot study. J. Digit Imaging 8(2), 88-94.
86. J. Yang, G. Xu, H. Kong, Y. Zheng, T. Pang and Q. Yang (2002) Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 780(1), 27-33.
87. Z.H. Zhou, Y. Jiang, Y.B. Yang and S.F. Chen (2002) Lung cancer cell identification based on artificial neural network ensembles. Artif. Intell. Med. 24(1), 25-36.
88. A.R. Zlotta, M. Remzi, P.B. Snow, C.C. Schulman, M. Marberger and B. Djavan (2003) An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less. J. Urol. 169(5), 1724-1728.